1. Home
  2. PAVS vs CTMX Comparison

PAVS vs CTMX Comparison

Compare PAVS & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAVS
  • CTMX
  • Stock Information
  • Founded
  • PAVS 2004
  • CTMX 2008
  • Country
  • PAVS United States
  • CTMX United States
  • Employees
  • PAVS N/A
  • CTMX N/A
  • Industry
  • PAVS Medicinal Chemicals and Botanical Products
  • CTMX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PAVS Health Care
  • CTMX Health Care
  • Exchange
  • PAVS Nasdaq
  • CTMX Nasdaq
  • Market Cap
  • PAVS 90.2M
  • CTMX 85.3M
  • IPO Year
  • PAVS 2019
  • CTMX 2015
  • Fundamental
  • Price
  • PAVS $1.36
  • CTMX $0.84
  • Analyst Decision
  • PAVS
  • CTMX Buy
  • Analyst Count
  • PAVS 0
  • CTMX 6
  • Target Price
  • PAVS N/A
  • CTMX $5.77
  • AVG Volume (30 Days)
  • PAVS 12.2K
  • CTMX 847.0K
  • Earning Date
  • PAVS 01-01-0001
  • CTMX 03-10-2025
  • Dividend Yield
  • PAVS N/A
  • CTMX N/A
  • EPS Growth
  • PAVS N/A
  • CTMX N/A
  • EPS
  • PAVS N/A
  • CTMX 0.16
  • Revenue
  • PAVS $6,544,819.00
  • CTMX $126,617,000.00
  • Revenue This Year
  • PAVS N/A
  • CTMX $22.55
  • Revenue Next Year
  • PAVS N/A
  • CTMX N/A
  • P/E Ratio
  • PAVS N/A
  • CTMX $5.20
  • Revenue Growth
  • PAVS N/A
  • CTMX 33.66
  • 52 Week Low
  • PAVS $0.32
  • CTMX $0.79
  • 52 Week High
  • PAVS $2.52
  • CTMX $5.85
  • Technical
  • Relative Strength Index (RSI)
  • PAVS 56.61
  • CTMX 45.15
  • Support Level
  • PAVS $1.31
  • CTMX $0.82
  • Resistance Level
  • PAVS $1.38
  • CTMX $0.98
  • Average True Range (ATR)
  • PAVS 0.05
  • CTMX 0.06
  • MACD
  • PAVS -0.01
  • CTMX 0.01
  • Stochastic Oscillator
  • PAVS 50.00
  • CTMX 33.58

About PAVS Paranovus Entertainment Technology Ltd.

Paranovus Entertainment Technology Ltd through its subsidiary, is engaged in the AI-powered entertainment industry, aiming to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It is planning to launch SimTwin application which will allow users to interact with digital versions of people and capture life moments. The company also has a software development agreement with Blueline Studios Inc which is developing 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: